First Light Diagnostics logo — company profile

First Light Diagnostics

Founded 2006 United States Chelmsford, United States 27 employees Grant Total: $37.48M Biotechnology, Health Care +1

General Information

Company Name First Light Diagnostics
Founded Year 2006
Location United States Chelmsford, United States
Employees 27
Industries Biotechnology, Health Care, Information Technology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with First Light Diagnostics. To contact First Light Diagnostics, visit firstlightdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does First Light Diagnostics compare?

A PDF of First Light Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting First Light Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About First Light Diagnostics

First Light Diagnostics, founded in 2006 and headquartered in the United States, is a biotechnology and healthcare company that focuses on developing innovative diagnostic tests for the rapid and accurate detection of life-threatening pathogens. The company's proprietary MultiPath™ technology enables the rapid identification of pathogens responsible for infections, allowing for appropriate treatment options to be delivered within hours instead of days. This capability is made possible through the company's antimicrobial susceptibility tests. Notably, the company received a $4.00M grant investment on 27 October 2020 from the Biomedical Advanced Research and Development Authority (BARDA), signifying their potential for growth and recognition within the industry. As the need for rapid and accurate diagnostic tools in healthcare continues to grow, First Light Diagnostics presents itself as a promising investment opportunity with a mission to save lives, lower healthcare costs, improve antibiotic stewardship, and prevent the spread of antibiotic drug resistance through their innovative solutions.

Business keywords: diagnostic tests, pathogen detection, antimicrobial susceptibility, rapid diagnostics, Healthcare-Associated Infections (HAI), antibiotic stewardship, antibiotic drug-resistance, automated medical diagnostics, MultiPath technology, infectious agents testing, hospital infections, healthcare costs, antibiotic treatment, clinical studies, laboratory tests

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $4.00M 1
Biomedical Advanced Research and Development Authority (BARDA)
27 Oct 2020
Post IPO Debt $1.10M 1
U.S. Small Business Administration
19 May 2020
Grant $4.30M 1
Biomedical Advanced Research and Development Authority (BARDA)
18 Dec 2019
Debt Financing $4.50M 1
MassDevelopment
20 Jun 2019
Series A $8.25M 6
Beacon Angels, Life Science Angels +4
16 Jan 2019
Venture Round $3.00M -
30 Jul 2018
Series A $811.18K 1
Keiretsu Capital
25 Jul 2016
Debt Financing $750.00K 1
Massachusetts Life Sciences Center
26 May 2016
Series A $2.87M 2
Keiretsu Capital, Keiretsu Forum Northwest
16 Sep 2015
Grant $4.00M 1
National Institutes of Health
01 Feb 2015

View All 14 Funding Rounds

First Light Diagnostics Alternatives & Competitors

View All Alternatives
First Light Diagnostics vs

Improving quality of life for patients by providing antimicrobial stewardship in a cost-effective ma...

Seed
13 employees
Biotechnology, Health Care
First Light Diagnostics vs
Pattern Bioscience
Pattern Bioscience United States

Our mission is simple: We will improve the world's most important health decisions.

Series C
76 employees
Biotechnology, Health Care
First Light Diagnostics vs

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care

FAQ About First Light Diagnostics

First Light Diagnostics develops innovative diagnostic tests that enable rapid and accurate detection of pathogens that can cause life-threatening infections. Our antimicrobial susceptibility tests will help ensure that patients suffering from infection receive appropriate antibiotic treatment optio...
First Light Diagnostics was founded in 2006.
First Light Diagnostics is headquartered in Chelmsford, United States.
First Light Diagnostics operates in Biotechnology, Health Care and Information Technology. Its work centres on diagnostic tests, pathogen detection, antimicrobial susceptibility and rapid diagnostics.
First Light Diagnostics has approximately 27 employees.
First Light Diagnostics has completed 14 funding rounds, raising a total of $37.48M. The latest funding stage is Grant.
Top alternatives and competitors to First Light Diagnostics include Microplate Dx Limited, Pattern Bioscience, EMPE Diagnostics, Day Zero Diagnostics, Inc, Selux Diagnostics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
First Light Diagnostics and Microplate Dx Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for First Light Diagnostics, https://bouncewatch.com/company/first-light-diagnostics, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes